Douglas S. Hawkins - Concepedia

Author

Douglas S. Hawkins

Also Known As

D Hawkins, D S Hawkins, D. Hawkins, D. S. Hawkins, D.S. Hawkins, DOUGLAS HAWKINS, Douglas Hawkins, Douglas S Hawkins, Douglas S. Hawkins, Douglas S. Hawkins

479

Publications

21K

Citations

H-Index

125

Concepts

All Affiliations

Seattle Children's Hospital University of Washington Fred Hutch Cancer Center Cancer Research Center University of Southern California

About

Douglas S. Hawkins is an author at Seattle Children's Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	61	3.3K
2	Health Sciences	17	25	945
3	Public Health	4	4	96
4	Natural Sciences	2	2	150
5	Engineering	1	1	35

Douglas S. Hawkins

183

Publications

16.9K

Citations

H-Index

Page 1

	Year	Citations
Efficacy of Larotrectinib in <i>TRK</i> Fusion–Positive Cancers in Adults and Children Alexander Drilon, Theodore W. Laetsch, Shivaani Kummar, New England Journal of Medicine	2018	2.6K
Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors Jack F. Shern, Li Chen, Juliann Chmielecki, Cancer Discovery	2014	759
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort Sigbjørn Smeland, Stefan Bielack, Jeremy Whelan, European Journal of Cancer	2019	700
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study Theodore W. Laetsch, Steven G. DuBois, Leo Mascarenhas, The Lancet Oncology Tumoral PathologyMedicinePathologyPaediatric Solid TumoursCancer Genetics	2018	536
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial Neyssa Marina, Sigbjørn Smeland, Stefan Bielack, The Lancet Oncology	2016	511
Genome-Informed Targeted Therapy for Osteosarcoma Leanne C. Sayles, Marcus R. Breese, Amanda Koehne, Cancer Discovery	2018	445
Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803 Carola A.S. Arndt, Julie A. Stoner, Douglas S. Hawkins, Journal of Clinical Oncology	2009	363
Targeting Oxidative Stress in Embryonal Rhabdomyosarcoma Xiang Chen, Elizabeth Stewart, Anang A. Shelat, Cancer Cell Reductive StressReactive Oxygen SpecieMedicineCell BiologyRedox Biology	2013	300
[<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography Predicts Outcome for Ewing Sarcoma Family of Tumors Douglas S. Hawkins, Scott M. Schuetze, James E. Butrynski, Journal of Clinical Oncology	2005	282
Survival After Relapse in Children and Adolescents With Rhabdomyosarcoma: A Report From the Intergroup Rhabdomyosarcoma Study Group Alberto S. Pappo, James R. Anderson, William M. Crist, Journal of Clinical Oncology	1999	270

Page 1